The single most important heart medication for dogs is pimobendan, a drug that both strengthens the heart’s pumping ability and relaxes blood vessels. In the landmark EPIC clinical trial, dogs with early heart enlargement that received pimobendan lived a median of 462 days longer before developing heart failure compared to untreated dogs. But pimobendan is rarely used alone. Most dogs with heart disease end up on a combination of medications tailored to how far the disease has progressed.
Why There’s No Single “Best” Heart Medicine
Canine heart disease is classified into stages (A through D), and the right medication depends entirely on which stage your dog is in. A dog with early, silent heart enlargement needs a completely different approach than one actively struggling to breathe. In the earliest stages, no medication is recommended at all. Treatment only begins once the heart has physically changed shape and size enough to warrant intervention.
The most common form of heart disease in dogs is degenerative mitral valve disease, where the valve between the left chambers of the heart slowly deteriorates and allows blood to leak backward. Small breeds like Cavalier King Charles Spaniels, Dachshunds, and Chihuahuas are especially prone. Large breeds more commonly develop a condition called dilated cardiomyopathy, where the heart muscle weakens and stretches. The medications overlap significantly, but the priorities can differ.
Pimobendan: The Cornerstone Drug
Pimobendan works through two mechanisms at once. It makes the heart muscle contract more forcefully by increasing the sensitivity of cardiac cells to calcium, and it widens blood vessels by blocking a specific enzyme. This dual action means the heart pumps more effectively while also facing less resistance with each beat. For a failing heart, that combination is transformative.
Veterinary cardiologists now recommend starting pimobendan before a dog ever shows symptoms of heart failure, as long as imaging confirms the heart has begun to enlarge (Stage B2). This was a major shift in treatment philosophy driven by the EPIC trial results. Dogs prescribed pimobendan at this preclinical stage experienced 311 fewer days of health lost to heart failure over a five-year window compared to dogs who didn’t receive it. That’s nearly a full extra year of normal life before the disease progresses. Pimobendan continues as a core medication through every subsequent stage of disease. The most common side effect owners notice is occasional diarrhea.
ACE Inhibitors: Reducing the Heart’s Workload
Once a dog develops actual heart failure symptoms (coughing, rapid breathing, fatigue, fluid buildup), an ACE inhibitor is typically added to the regimen. These drugs, most commonly enalapril or benazepril, interrupt a hormonal chain reaction that makes heart failure worse. When the heart weakens, the kidneys respond by activating a system that retains salt and water and constricts blood vessels, essentially increasing the workload on an already struggling heart. ACE inhibitors block this cycle, allowing blood vessels to relax and reducing fluid retention.
The practical result for your dog is lower blood pressure, less fluid accumulating in the lungs, better exercise tolerance, and a heart that doesn’t have to work as hard. One important difference from human medicine: ACE inhibitors commonly cause coughing in people, but this side effect is rare in dogs. However, many dogs who need these medications are already coughing from their heart disease, which can cause confusion. The more concerning side effects to watch for are lethargy, weakness, or difficulty standing, all signs of blood pressure dropping too low. Because ACE inhibitors affect kidney function, your vet will monitor bloodwork periodically to check kidney values.
Diuretics: Managing Fluid Buildup
Furosemide is the workhorse diuretic in canine heart failure. It acts on the kidneys to block the reabsorption of sodium and water, which directly reduces the fluid overload that causes coughing, labored breathing, and abdominal swelling. In an emergency, when a dog comes in gasping from fluid in the lungs, furosemide is typically the first drug administered. For long-term management, it’s given orally, usually twice daily.
The challenge with furosemide is that the body can become resistant to it over time, requiring higher doses. When doses climb too high, a stronger loop diuretic called torsemide may be substituted. Your vet will adjust the diuretic dose to the lowest amount that keeps symptoms controlled, since higher doses increase the risk of dehydration and kidney stress.
Spironolactone is a milder diuretic that works differently. It blocks the hormone aldosterone, which drives salt and water retention. It’s often added alongside furosemide because it provides a modest additional diuretic effect while also helping preserve potassium levels that furosemide tends to deplete. Some evidence suggests spironolactone may also help slow harmful remodeling of the heart muscle itself.
Medications for Heart Rhythm Problems
Some dogs with advanced heart disease develop atrial fibrillation, an irregular rhythm where the upper chambers of the heart quiver chaotically instead of contracting in sync. This drives the heart rate dangerously high, sometimes above 140 beats per minute even at rest. In these cases, digoxin and diltiazem may be prescribed, often together. A study of 18 dogs with chronic atrial fibrillation found that combining both drugs controlled the heart rate significantly better than either one alone. These medications aren’t part of standard heart failure treatment and are only added when a specific rhythm disturbance is identified.
What a Typical Treatment Plan Looks Like
For most dogs, heart disease treatment builds in layers as the condition progresses:
- Early heart enlargement, no symptoms (Stage B2): Pimobendan alone.
- First signs of heart failure (Stage C): Pimobendan plus an ACE inhibitor plus furosemide. Spironolactone is commonly added as well.
- Advanced or treatment-resistant heart failure (Stage D): All of the above at adjusted doses, potentially with torsemide replacing furosemide, and additional medications as needed for specific complications like arrhythmias.
Even with advanced heart failure, the outlook is better than many owners expect. A study of 54 dogs with advanced disease (defined as heart failure recurring despite standard triple therapy) found a median survival time of 281 days after that advanced diagnosis, with some dogs living over two years.
Supplements With Cardiac Benefits
Several nutritional supplements have shown evidence of supporting heart function in dogs. Omega-3 fatty acids from fish oil can help reduce inflammation and may slow muscle wasting that accompanies chronic heart failure. Taurine and L-carnitine are amino acids that play direct roles in heart muscle energy production. Taurine deficiency, in particular, has been linked to dilated cardiomyopathy in certain breeds. Coenzyme Q10 and vitamin E have also been studied for their roles in protecting cardiac cells from oxidative damage. These supplements don’t replace medications, but research suggests appropriate levels can improve quality of life, reduce symptoms, and in some cases improve survival.
Monitoring Your Dog at Home
One of the most valuable things you can do for a dog with heart disease is track their resting respiratory rate. While your dog is sleeping or resting calmly, count the number of breaths in 60 seconds (one rise and fall of the chest equals one breath). A consistently normal rate is below 30 breaths per minute. If your dog’s sleeping breathing rate regularly exceeds 30, or if you notice a sudden upward trend from their usual baseline, this is one of the earliest and most reliable signs that fluid is building up in the lungs. Combined with other warning signs like reduced appetite, reluctance to exercise, or a swollen belly, an elevated resting respiratory rate can signal that medications need adjusting before a full crisis develops.